Despite marked reductions in environmental sources of lead and increased protection from occupational lead exposure, the Center for Disease Control and Prevention (CDC) states that lead exposure on the job remains a significant health ...
Tags: Lead, coating, printing, Blood lead
Obesity increases the risk of developing kidney disease, a new study suggests. Moreover, declines in kidney function can be detected long before people develop other obesity-related diseases such as diabetes and high blood pressure, the ...
Tags: Obesity, Kidney Function, Health News
Controlling dietary acid intake by increasing consumption of fruits and vegetables could help improve kidney health, according to three new studies from the US and Japan. The studies were presented at the ASN Kidney Week 2013 held at the ...
Tags: Agriculture, Food
NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
PLC Medical Systems has been granted a new method patent by the US Patent and Trademark Office, titled, 'Patient Hydration Method.' The patent claims cover the use of RenalGuard Therapy and the RenalGuard device to protect patients' ...
St. Jude Medical, a medical device firm, has announced that its EnligHTN Multi-Electrode Renal Denervation System offers a safe, rapid and sustained reduction in measurements of blood pressure after a year. The company presented the new ...
Tags: EnligHTN Renal, Blood Pressure
The USFDA has accepted Otsuka Pharmaceutical's new drug application (NDA) of tolvaptan for priority review to treat autosomal dominant polycystic kidney disease (ADPKD). The filing was based on Phase III clinical trial results of the drug ...
Tags: Otsuka Tolvaptan NDA, Medicine
Argutus Medical was chosen as one of ten companies to display their latest product at the Innovators Place™ during the American Society of Nephrology (ASN) Kidney Week 2012. The scientific exposition, which took place from the 1st ...
Tags: AKI Test, Innovators Place, Argutus Medical
The European Medicines Agency (EMA) has granted orphan drug status to AlphaCore Pharma's ACP-501 (rhLCAT) to treat familial LCAT deficiency (FLD). FLD causes lipid deposition in eyes, red blood cells and kidneys which can lead to corneal ...
Tags: EMA, orphan drug status, AlphaCore FLD